I want to get continuous structured data on emerging clinical best practices, evidence-based guidelines, and value-based care model outcomes from medical journals, academic research portals, and competitor health system innovation sites.
A shared demo template. Read-only preview of what would be monitored in a real pilot.
Click to explore each section
This is a real demo!
Click to explore each section.
Jsonify Configuration Template
Goal
I want to get continuous structured data on emergi...
Access continuous insights on clinical best practices and outcomes — effortlessly automated from the latest research and innovation.
12 website or app sources
The Jsonify AI will open these automatically to explore and find your information
10
data columns
12
dashboard widgets
3
integrations
1
notification
Data sources are the websites and apps where information will be collected from. These can be changed or expanded at any time. This is turned into data rows.
Sample data preview. This is synthetic test data generated to illustrate the structure. Real data from your sources will be populated during the pilot. This data powers the dashboard widgets.
| id | Source | Title | StudyType | Population | PrimaryOutcome | EffectSize | CostEstimate | Status | LastUpdated | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
|
Implementation of outpatient antibiotic stewardship reduces inappropriate prescriptions in primary care: cluster-randomized trial ... show all |
Cluster-randomized trial | Primary care clinics; adults and children (n=8,420 encounters) | Proportion of inappropriate antibiotic prescriptions within 30 days | Relative reduction 28% (95% CI 22–34) | $12,400 per clinic implementation (USD) | Published | Feb 2, 2026 | ||
| 2 |
|
Telehealth cardiac rehab vs center-based: randomized noninferiority trial | Randomized controlled trial | Post-MI patients (n=620), mean age 61 | 6-minute walk distance at 12 weeks | Noninferior; mean difference -8m (95% CI -14 to -2) | Estimated program cost $1,150 per patient (USD) | Active, Completed | Feb 3, 2026 | ||
| 3 |
|
Value-based bundled payments for hip fracture reduce LOS without increased readmissions | Observational cohort | Older adults with hip fracture (n=3,200) | Length of stay and 30-day readmission rate | LOS reduced by 1.6 days; readmission unchanged (RR 1.03) | Average savings $3,200 per admission (USD) | Published | Feb 1, 2026 | ||
| 4 |
|
Early dexamethasone and steroid-sparing outcome in severe pneumonia: multi-center RCT | Multi-center randomized controlled trial | Adults with severe community-acquired pneumonia (n=1,450) | 30-day mortality | Absolute risk reduction 3.2% (95% CI 1.1–5.3) | Incremental drug cost $18 per patient (USD) | Published | Feb 2, 2026 | ||
| 5 |
|
Accountable care organizations with social needs navigation lower total cost for high-risk patients | Quasi-experimental difference-in-differences | High-risk Medicare beneficiaries (n=12,100) | Annual per-beneficiary total cost | $1,150 savings per beneficiary/year (95% CI $600–$1,700) | Program cost $420 per beneficiary/year (USD) | Published | Feb 3, 2026 | ||
| 6 |
|
Tumor genomic-guided therapy improves progression-free survival in metastatic colorectal cancer | Prospective cohort | Metastatic CRC patients receiving NGS-guided therapy (n=480) | Progression-free survival | Median PFS 9.8 vs 6.1 months (HR 0.68) | NGS panel cost $2,900 per patient (USD) | Published guideline update | Feb 4, 2026 | ||
| 7 |
|
Low-dose CT screening outreach increases lung cancer stage I detection in rural populations | Program evaluation | Rural eligible smokers (n=9,760 invited) | Proportion diagnosed at stage I | Stage I detection increased from 18% to 33% (RR 1.83) | Outreach cost $85 per screened person (USD) | Report published | Feb 3, 2026 | ||
| 8 |
|
Clinical decision support reduced opioid prescribing after ED discharge: pragmatic study | Pragmatic controlled study | ED discharges with acute pain (n=15,300 encounters) | Morphine milligram equivalents prescribed per encounter | Mean MME reduced by 22% (95% CI 19–25) | CDS implementation $7,600 per facility (USD) | Published | Feb 2, 2026 | ||
| 9 |
|
FHIR-based interoperability pilot improves medication reconciliation accuracy | Pilot implementation study | Two-hospital health system; adult inpatients (n=4,200) | Medication discrepancies per patient at discharge | Discrepancies reduced by 1.9 per patient (p<0.001) | Pilot build cost $145,000 (USD) | Completed pilot | Feb 4, 2026 | ||
| 10 |
|
Home-based palliative care reduces emergency visits among advanced heart failure patients | Matched cohort study | Advanced HF patients (n=1,240 matched pairs) | ED visits per patient-year | ED visits reduced by 37% (IRR 0.63) | Program cost $3,800 per patient/year (USD) | Published | Feb 1, 2026 | ||
| 11 |
|
Point-of-care CRP testing in primary care reduces antibiotic prescribing for respiratory infections | Randomized controlled trial | Adults with acute respiratory symptoms (n=2,900) | Antibiotic prescription rate within 7 days | Absolute reduction 16% (95% CI 12–20) | POC test cost $6 per test; incremental cost $48 per reduction in prescription (USD) | Published | Feb 3, 2026 | ||
| 12 |
|
Integrated mental health stepped-care lowers PHQ-9 scores in community clinics | Stepped-wedge trial | Primary care patients with depression (n=2,120) | Change in PHQ-9 at 12 weeks | Mean reduction 4.1 points vs 2.6 in control (mean difference 1.5) | Per-patient program cost $220 (USD) | Preprint poster | Feb 2, 2026 | ||
| 13 |
|
Short-course vs standard-duration antibiotic therapy for uncomplicated pyelonephritis | Randomized noninferiority trial | Women 18–65 with uncomplicated pyelonephritis (n=1,100) | Clinical cure at day 14 | Short-course noninferior; difference -0.8% (95% CI -3.6–1.9) | Medication cost reduction $34 per patient (USD) | Published | Feb 3, 2026 | ||
| 14 |
|
AI triage tool to prioritize stroke alerts in EDs: multicenter validation | Prospective validation study | ED stroke code activations (n=4,800) | Sensitivity for LVO detection | Sensitivity 92% (95% CI 90–94) | Estimated licensing $45,000 per hospital/year (USD) | Recruiting, interim results | Feb 4, 2026 | ||
| 15 |
|
Remote monitoring in COPD reduces exacerbation-related hospitalizations | Randomized controlled trial | Moderate–severe COPD patients (n=980) | Hospitalization rate for exacerbation at 12 months | Relative reduction 29% (95% CI 18–40) | Remote monitoring cost $650 per patient/year (USD) | Published | Feb 2, 2026 | ||
| 16 |
|
Single-dose HPV vaccine provides durable protection: 10-year follow-up cohort | Longitudinal cohort | Adolescent girls and young women vaccinated (n=6,500) | Incident HPV 16/18 infection | Vaccine efficacy 87% (95% CI 82–91) at 10 years | Vaccine program cost per person $42 (USD) | Published | Feb 3, 2026 | ||
| 17 |
|
Medicaid ACOs with behavioral health integration lower total cost of care | Difference-in-differences | Medicaid beneficiaries in states with ACO pilots (n=45,600) | Per-member-per-month spending | Decrease $28 PMPM (95% CI $15–$41) | Integration start-up $2.1M per state pilot (USD) | Published | Feb 1, 2026 | ||
| 18 |
|
Adjuvant immunotherapy duration optimization in melanoma: consensus update | Guideline consensus | Resected stage III–IV melanoma patients | Recurrence-free survival recommendations | Recommended 6 months may be sufficient for low-risk subgroup; pooled HR 0.95 | Estimated drug cost reduction $48,000 per patient when shortened (USD) | Guideline updated | Feb 4, 2026 | ||
| 19 |
|
Routine germline testing increases actionable variants detection in pancreatic cancer | Prospective registry | Patients with pancreatic adenocarcinoma (n=1,320) | Proportion with actionable germline variants | Actionable variants detected in 9.7% vs historical 4.1% | Testing cost $1,200 per patient (USD) | Report published | Feb 2, 2026 | ||
| 20 |
|
Enhanced recovery pathways reduce opioid use and LOS after colorectal surgery | Systematic review and meta-analysis | Adult colorectal surgery patients across 18 studies (n≈22,400) | Opioid consumption and length of stay | Opioid use reduced 41%; LOS reduced 0.9 days (95% CI 0.6–1.2) | Per-patient implementation cost $320 (USD) | Published | Feb 3, 2026 | ||
| 21 |
|
User-centered EHR redesign improves clinician documentation time and satisfaction | Before-after implementation study | Primary care physicians (n=142) | Mean documentation time per patient | Time reduced by 6.4 minutes (p<0.001); satisfaction score +18% | Redesign cost $380,000 (USD) | Completed | Feb 2, 2026 | ||
| 22 |
|
SGLT2 inhibitors decrease hospitalization for heart failure in patients with CKD | Meta-analysis of RCTs | Patients with CKD stages 3–4 (n≈16,800 pooled) | HF hospitalization rate | Relative risk 0.72 (95% CI 0.65–0.80) | Annual drug cost $4,200 per patient (USD) | Published | Feb 1, 2026 | ||
| 23 |
|
Rapid SARS-CoV-2 antigen testing in hospitals shortens isolation time without increasing transmission ... show all |
Stepped-wedge cluster trial | Hospital inpatients under suspected COVID-19 isolation (n=5,600) | Median isolation duration | Isolation reduced by 28 hours; no increase in nosocomial transmission (IRR 1.02) | Testing program cost $3.10 per test (USD) | Published | Feb 4, 2026 | ||
| 24 |
|
Community paramedicine program reduces avoidable ED visits among frail elders | Prospective matched cohort | Homebound elders referred to community paramedics (n=760) | Avoidable ED visits at 6 months | Reduced by 44% (RR 0.56) | Program cost $1,020 per patient (USD) | Preprint | Feb 2, 2026 | ||
| 25 |
|
Low-dose chemoradiation with immunotherapy shows promising pathologic complete response in esophageal cancer ... show all |
Phase II single-arm trial | Locally advanced esophageal adenocarcinoma (n=86) | Pathologic complete response rate | pCR 41% (95% CI 30–52) | Estimated regimen cost $38,500 per patient (USD) | Published | Feb 3, 2026 | ||
| 26 |
|
Wearable glucose sensor to guide insulin dosing in type 1 diabetes: randomized crossover | Randomized crossover trial | Adults with T1D using MDI (n=210) | Time in range (70–180 mg/dL) over 12 weeks | Increase in TIR by 6.8 percentage points (95% CI 4.2–9.4) | Sensor annualized cost $1,100 per patient (USD) | Completed, results posted | Feb 4, 2026 | ||
| 27 |
|
Pharmacist-led medication reconciliation at discharge reduces 30-day readmissions | Cluster randomized trial | General medicine discharges (n=6,300 patients) | 30-day readmission rate | Absolute reduction 2.1% (95% CI 1.0–3.2) | Per-hospital annual cost $92,000 (USD) | Published | Feb 1, 2026 | ||
| 28 |
|
Single-visit cervical cancer screening with HPV self-sampling effective in low-resource settings | Randomized pragmatic trial | Screen-eligible women in LMICs (n=11,200) | Screen-and-treat completion rate | Completion increased from 57% to 84% (RR 1.47) | Per-woman program cost $9.50 (USD) | Published | Feb 2, 2026 | ||
| 29 |
|
Price-transparency tool for imaging reduces low-value MRI ordering | Interrupted time series | Primary care clinicians ordering imaging (n=2,400 clinicians) | Rate of low-value MRI orders per 1,000 visits | Reduced by 12% (95% CI 7–17) | Tool development $58,000; estimated annual maintenance $9,600 (USD) | Published | Feb 3, 2026 | ||
| Looking for more? Great news − this is just a small sample. Jsonify production workflows process anywhere from tens of thousands to millions of real data rows per run! | |||||||||||
From
–
To
Filters
Loading filters...
Loading filters...
Total Clinical Guidelines Retrieved
2,456
total clinical guidelines retrieved
8%
Distribution of Guidelines by Specialty
Most Cited Articles on Best Practices
Total Research Articles Analyzed
2,467
total research articles analyzed
8%
Trends in Value-Based Care Outcomes
Key Findings on Evidence-Based Guidelines
Recent studies show a 25% increase in adherence to evidence-based guidelines in oncology treatments since 2025.
Research indicates a significant correlation between value-based care models and improved patient outcomes, particularly in chronic disease management.
Emerging best practices emphasize interdisciplinary collaboration, which has been linked to a 15% reduction in hospital readmission rates.
Emerging Best Practices Over Time
Latest Research Articles
| Title | Authors | Journal | Publication Date | Summary |
|---|---|---|---|---|
| Impact of Telemedicine on Healthcare Delivery | Smith J., Doe A. | JAMA Network | 2026-01-15 | Explores how telemedicine improves access to care and patient outcomes. |
| Guidelines for Management of Chronic Pain | Johnson R., Lee K. | The Lancet | 2026-01-20 | Presents evidence-based strategies for chronic pain management in diverse populations. |
| Value-Based Care Models in Oncology | Brown T., Garcia M. | Health Affairs | 2026-01-25 | Analyzes outcomes of value-based care models in cancer treatment. |
| Emerging Trends in Preventive Healthcare | White P., Kim J. | BMJ | 2026-01-30 | Discusses innovative preventive healthcare practices and their effectiveness. |
| Clinical Trials on Novel Therapies for Diabetes | Chen L., Patel N. |
|
2026-02-01 | Reviews recent clinical trials targeting new diabetes therapies and their results. |
Summary of Recent Innovations in Competitor Health Systems
Recent studies published in JAMA and The Lancet show a significant shift towards telehealth integration in patient care models across leading health systems.
Emerging evidence-based guidelines from NCCN highlight the effectiveness of personalized treatment plans in oncology, which are being adopted by competitors.
Health Affairs reports a 25% increase in patient satisfaction scores related to value-based care models implemented by major health systems in the past year.
Clinical trials.gov indicates a growing number of trials focusing on AI applications in healthcare, suggesting a trend towards technology-driven patient outcomes.
Research from BMJ underscores the importance of interdisciplinary collaboration in improving clinical outcomes, which is being actively pursued by competitor systems.
Top 5 Sources for Clinical Guidelines
Clinical Trials in Progress
| Trial Name | Phase | Condition | Start Date | Source |
|---|---|---|---|---|
| A Study of Drug A in Patients with Condition X | Phase 2 | Condition X | 2025-06-15 |
|
| Effectiveness of Treatment B on Condition Y | Phase 3 | Condition Y | 2026-01-10 |
|
| Long-term Outcomes of Procedure C for Condition Z | Phase 1 | Condition Z | 2025-12-01 |
|
| Comparative Study of Device D vs. Standard Care | Phase 2 | Condition W | 2025-08-20 |
|
| Evaluation of Protocol E in Cancer Patients | Phase 3 | Cancer | 2026-02-01 |
|
| Innovative Approach to Treat Condition V | Phase 1 | Condition V | 2025-11-15 |
|
| Impact of Intervention F on Patient Outcomes | Phase 2 | Condition U | 2026-01-25 |
|
Evidence Sources by Publication Type
Structured data feeds are included — we're happy to help with API integration and automation.
JSON
Loading...
CSV
Loading...
Looking for more? Great news − this is just a small sample. Typically, our commercial customers process tens of thousands to millions of data points per task!
Radar continuously monitors your selected web sources and alerts you the moment something changes.
+7
Recent change
New Research Article
5m ago
Emerging Clinical Practices published in JAMA Network
Recent change
Clinical Trial Update
Yesterday
New Cancer Treatment Trial status changed to recruiting
Recent change
New Guideline Released
12m ago
NCCN Guidelines updated for breast cancer
Recent change
New Value-Based Outcome
12m ago
Value-Based Care Model published in Health Affairs
Recent change
Research Gap Identified
12m ago
Lack of Studies on Telehealth missing from recent publications
Data connections determine where the collected data will be delivered. You can add, remove, or change connections at any time.
Scroll down to see more